Pharma & Biotech

The stock market chapter for Walgreens Boots Alliance has officially closed. Sycamore Partners, a major private equity firm, has finalized...

BioNTech's corporate narrative is expanding beyond its Mainz headquarters, with Africa emerging as a crucial theater for its future operations....

After experiencing a severe decline that wiped out more than 80% of its value in September, aTyr Pharma is demonstrating...

A fascinating divergence is unfolding around Axsome Therapeutics, creating a clear puzzle for market observers. On one side, heavyweight investment...

The biotechnology sector is buzzing with activity, and Incyte finds itself at the heart of investor attention. Despite a recent...

Pharmaceutical giant Bristol-Myers Squibb is making a substantial $1.5 billion strategic move to acquire biotechnology firm Orbital Therapeutics, signaling a...

Investor attention has turned to Assembly Biosciences following the release of new clinical trial data for its experimental herpes treatment....

The European Union has confirmed a substantial €95 million investment in BioNTech's mRNA production facility in Rwanda, marking a significant...

InfuSystem Holdings, Inc. finds itself in a severe downturn, with its equity value experiencing a steep decline that appears to...

The landscape at Walgreens Boots Alliance is undergoing significant transformation in the wake of its acquisition by Sycamore Partners, with...